Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/asj/sjad060 | DOI Listing |
Eur Respir J
January 2025
Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Eur Respir J
January 2025
Center for Congenital Heart Diseases, Paediatric and Congenital Cardiology, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
J Cosmet Dermatol
December 2024
Department of Plastic and Cosmetic Reconstructive Surgery, Henri Mondor Hospital, Créteil, France.
Introduction: Glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide, have revolutionized the treatment of diabetes and obesity by promoting significant weight loss through incretin effects. However, rapid weight reduction induced by these medications often leads to esthetic challenges, including facial volume loss, skin laxity, and body contour irregularities. This commentary reviews the esthetic consequences of GLP-1-induced weight loss and explores solutions for managing these concerns in clinical practice.
View Article and Find Full Text PDFNeurosurgery
December 2024
Lillian S. Wells Department of Neurosurgery, University of Florida, Gainesville, Florida, USA.
Circ Cardiovasc Imaging
December 2024
MIRACL.ai Laboratory, Multimodality Imaging for Research and Analysis Core Laboratory and Artificial Intelligence, University Hospital of Lariboisiere (AP-HP), Paris, France (T.P., S.T.).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!